Clinical Trial Update: The Framingham Study: Examining DNA Markers and Links to Diseases

View source ↗

Summary

This update reports on The Framingham Study's examination of DNA markers and their links to cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Vascular Diseases | Status: COMPLETED